Canon Medical Systems, Stereotaxis Announce Technology Compatibility And Commercial Collaboration To Pair Alphenix Interventional Imaging Platform With Genesisx Robotic Magnetic Navigation System

• Collaboration brings together Canon’s Alphenix interventional fluoroscopy system and Stereotaxis’ GenesisX robotic technology
• Technologies will be presented at TCT 2026 in the Canon booth

TUSTIN, Calif. and ST. LOUIS, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Canon Medical Systems USA, a leader in innovative diagnostic imaging solutions, and Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced a technology compatibility and commercial collaboration to pair Canon Medical’s Alphenix interventional imaging platform with Stereotaxis’ GenesisX Robotic Magnetic Navigation system.

Canon and Stereotaxis are collaborating to offer their respective systems in a compatible fashion alongside each other. Canon Medical's Alphenix platform provides advanced imaging, visualization, dose-management and workflow capabilities for interventional cardiology, with flexible configurations designed to support complex procedures. GenesisX enables precise robotic navigation of interventional catheters, with a semi-mobile architecture designed to facilitate adoption broadly within existing catheterization labs without any construction.